NCT00747110View on ClinicalTrials.gov

Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC)

PHASE3CompletedINTERVENTIONAL
Enrollment

343

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2010

Conditions
Colitis, Ulcerative
Interventions
DRUG

budesonide

3x 3mg budesonide capsules once daily

DRUG

mesalazine

3x 1000mg mesalazine onc daily

Trial Locations (1)

92224

Klinikum St. Marien, Amberg

Sponsors
All Listed Sponsors
lead

Dr. Falk Pharma GmbH

INDUSTRY